Pharmacopées, ouvrages relatifs à la pharmacie et aux médicaments

<p>David H Reissner and Christopher A Langley<br><br>Twelfth Edition<br><br>Scheduled closure of pharmpress.com<br><br>ISBN 978 0 85711 420 4<br><br>Published Jul 2021<br><br>Paperback 234 x 156mm (600pp)<br><br><br>DESCRIPTION:<br><br> The new 12th edition of Dale and Appelbe’s Pharmacy and Medicines Law is your definitive guide to law for pharmacy practice in Great Britain. It covers law and professional regulation and is firmly established as the definitive reference work and student textbook on this subject in Great Britain. This edition has been extensively restructured and revised to include all the most recent changes to pharmacy laws and regulation. Updates include: Revised and restructured new edition of a highly successful text New chapters: introduction to the law, criminal and civil liability, medical devices, lawfully conducting a retail pharmacy business, confidentiality, data protection, and more Greater prominence to professional regulation and NHS chapters Over 50 additional cases than in previous editions to illustrate application of law Dale and Appelbe's Pharmacy and Medicines Law is an invaluable essential resource for pharmacy professionals and students who need access to current information on British law relating to medicines, poisons and the practice of pharmacy. About the Editors David H Reissner, is a solicitor who has spent more than 40 years specialising in pharmacy law. He is a Deputy District Judge and Chair of the Pharmacy Law &amp; Ethics Association. Christopher A Langley is Professor of Pharmacy Law and Practice and Head of Aston Pharmacy School at Aston University, Birmingham, UK. Dale and Appelbe's Pharmacy and Medicines Law Webinar Register to watch the webinar to hear the editors, David Reissner and Christopher Langley discuss what's new in the forthcoming edition, post-Brexit changes in legislation and COVID-19. <br>CONTENTS:<br><br> <br> Foreword <br> <br> About the contributors <br> <br> Introduction <br> <br> Legislation <br> <br> Cases <br> <br> Abbreviations and acronyms <br> <br> 1 Introduction to the law in Great Britain <br> <br> 2 The regulation of pharmacy and other healthcare professions <br> <br> 3 National Health Service law <br> <br> 4 Human medicines and medical devices: scope of regulations <br> <br> 5 Human medicines: the licensing system <br> <br> 6 Lawfully conducting a retail pharmacy business <br> <br> 7 Medicinal products subject to general sale <br> <br> 8 Human medicines: Pharmacy medicines <br> <br> 9 Human medicines: Prescription Only Medicines <br> <br> 10 Human medicines: exemptions from controls <br> <br> 11 Controlled drugs <br> <br> 12 Veterinary medicines <br> <br> 13 Human medicines: wholesale dealing and brokering <br> <br> 14 Human medicines: sale and supply of homoeopathic medicines <br> <br> 15 Herbal medicinal products <br> <br> 16 Human medicines: labelling, packaging and leaflets <br> <br> 17 Human medicines: advertising <br> <br> 18 Pharmacopoeias and compendia <br> <br> 19 Poisons, denatured alcohols and chemicals <br> <br> 20 Medical devices <br> <br> 21 Confidentiality and data protection <br> <br> 22 Professional conduct <br> <br> 23 Fitness to practise <br> <br> 24 Criminal and civil liability <br> <br> Appendices <br> <br> 1 The Standards for pharmacy professionals <br> <br> 2 Patient Group Directions <br> <br> 3 Schedule 1A to the Poisons Act: Regulated and Reportable Substances <br> <br> </p>

<p>The BP 2024 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023.<br><br> BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>27 new BP monographs, 17 new Ph. Eur. monographs.<br><br>93 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br><br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.<br><br>The BP 2024 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2023<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>

<p>KETOBEMIDONE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>INDINAVIR SULFATE - REFERENCE SPECTRUM</p>

<p>DIPOTASSIUM CLORAZEPATE MONOHYDRATE - REFERENCE SPECTRUM</p>

<p>RILMENIDINE DIHYDROGENOPHOSPHATE - REFERENCE SPECTRUM</p>

<p>PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>POLYSORBATE 40 - REFERENCE SPECTRUM</p>

<p>TIOCONAZOLE - REFERENCE SPECTRUM</p>

<p>MUPIROCIN - REFERENCE SPECTRUM</p>

<p>MESNA - REFERENCE SPECTRUM</p>

<p>DESFLURANE - REFERENCE SPECTRUM</p>

<p>TETRAZEPAM - REFERENCE SPECTRUM</p>

<p>2024 subscription to the European Pharmacopoeia<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023,<br>Supplement 11.5 published in January 2024.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2024 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.3) and the first two supplements (11.4-11.5), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2024 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023 and<br>Supplement 11.5 published in January 2024.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.3 to Supplement 11.5.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2023 to the end of December 2024.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.3) and two non-cumulative updates (11.4 and 11.5)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br>Supplement 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023 and<br>Supplement 11.5 published in January 2024.<br><br><br>Print version<br><br>The 11th Edition consists of three initial volumes (11.0) complemented by eight non-cumulative supplements (11.1 to 11.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.<br></p>

<p>METOPROLOL SUCCINATE - REFERENCE SPECTRUM</p>

<p>PENTOXYVERINE HYDROGEN CITRATE - REFERENCE SPECTRUM</p>

<p>POLYACRYLATE - REFERENCE SPECTRUM</p>

<p>GLYCERYL TRINITRATE - REFERENCE SPECTRUM</p>

<p>PRAVASTATIN SODIUM - REFERENCE SPECTRUM</p>

<p>IFOSFAMIDE - REFERENCE SPECTRUM</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.<br></p>

<p>CALCIPOTRIOL MONOHYDRATE - REFERENCE SPECTRUM</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>Installation of the application to 1 computer and to 1 USB stick, for online or offline use<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>TThe 2023 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.0) and the first two supplements (11.1-11.2), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2023 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>access, in English and French, until 31 December 2023 to the content of the initial release (11.0) and two cumulative updates (11.1 and 11.2)<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.0) and two non-cumulative updates (11.1 and 11.2)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2024 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.3) and the first two supplements (11.4-11.5), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2024 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023 and<br>Supplement 11.5 published in January 2024.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.3 to Supplement 11.5.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2023 to the end of December 2024.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.3) and two non-cumulative updates (11.4 and 11.5)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 2024 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.3) and the first two supplements (11.4-11.5), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2024 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Supplement 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023 and<br>Supplement 11.5 published in January 2024.<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>Online and downloadable access to Supplement 11.3 to Supplement 11.5.<br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2023 to the end of December 2024.<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.3) and two non-cumulative updates (11.4 and 11.5)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>CETOSTEARYL ISONONANOATE - REFERENCE SPECTRUM</p>

<p>SUFENTANIL - REFERENCE SPECTRUM</p>

<p>ESKETAMINE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>GLYCEROL (85 PER CENT) - REFERENCE SPECTRUM</p>

<p>MORPHINE HYDROCHLORIDE TRIHYDRATE - REFERENCE SPECTRUM</p>

<p>NORFLURANE - REFERENCE SPECTRUM</p>

<p>BENZYL BENZOATE - REFERENCE SPECTRUM</p>

<p>VINCRISTINE SULFATE - REFERENCE SPECTRUM</p>

<p>ETHANOL (ANHYDROUS) - REFERENCE SPECTRUM</p>

<p>PETHIDINE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>DIHYDROCODEINE HYDROGEN TARTRATE - REFERENCE SPECTRUM</p>

<p>VINDESINE SULFATE - REFERENCE SPECTRUM</p>

<p>TRICHLOROACETIC ACID - REFERENCE SPECTRUM</p>

<p>ETHYLMORPHINE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>PENTAZOCINE LACTATE - REFERENCE SPECTRUM</p>

<p>NAFTIDROFURYL - REFERENCE SPECTRUM</p>

<p>PHENYLMERCURIC BORATE - REFERENCE SPECTRUM</p>

<p>HALOTHANE - REFERENCE SPECTRUM</p>

<p>LATANOPROST - REFERENCE SPECTRUM</p>

<p>METACRESOL - REFERENCE SPECTRUM</p>